247 related articles for article (PubMed ID: 17348177)
21. Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer.
Abdalla I; Ray P; Ray V; Vaida F; Vijayakumar S
Urology; 1998 Feb; 51(2):300-5. PubMed ID: 9495715
[TBL] [Abstract][Full Text] [Related]
22. Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey.
Flynn-Evans EE; Mucci L; Stevens RG; Lockley SW
J Natl Cancer Inst; 2013 Sep; 105(17):1292-7. PubMed ID: 23943864
[TBL] [Abstract][Full Text] [Related]
23. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
[TBL] [Abstract][Full Text] [Related]
24. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
Lai SM; Keighley J; Garimella S; Enko M; Parker WP
JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
26. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
[TBL] [Abstract][Full Text] [Related]
27. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
[TBL] [Abstract][Full Text] [Related]
28. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
29. Relationship of demographic and clinical factors to free and total prostate-specific antigen.
Gelmann EP; Chia D; Pinsky PF; Andriole GL; Crawford ED; Reding D; Hayes RB; Kramer BS; Woodrum DL; Gohagan JK; Levin DL;
Urology; 2001 Oct; 58(4):561-6. PubMed ID: 11597539
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
32. Insufficient Lycopene Intake Is Associated With High Risk of Prostate Cancer: A Cross-Sectional Study From the National Health and Nutrition Examination Survey (2003-2010).
Lu Y; Edwards A; Chen Z; Tseng TS; Li M; Gonzalez GV; Zhang K
Front Public Health; 2021; 9():792572. PubMed ID: 34966715
[TBL] [Abstract][Full Text] [Related]
33. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
Abdalla I; Ray P; Vaida F; Vijayakumar S
Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
[TBL] [Abstract][Full Text] [Related]
34. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men.
Lee KM; Bryant AK; Lynch JA; Robison B; Alba PR; Agiri FY; Pridgen KM; DuVall SL; Yamoah K; Garraway IP; Rose BS
Cancer; 2024 Jan; 130(2):224-231. PubMed ID: 37927109
[TBL] [Abstract][Full Text] [Related]
35. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in operating characteristics of prostate cancer screening tests.
Smith DS; Bullock AD; Catalona WJ
J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
[TBL] [Abstract][Full Text] [Related]
37. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.
Cooney KA; Strawderman MS; Wojno KJ; Doerr KM; Taylor A; Alcser KH; Heeringa SG; Taylor JM; Wei JT; Montie JE; Schottenfeld D
Urology; 2001 Jan; 57(1):91-6. PubMed ID: 11164150
[TBL] [Abstract][Full Text] [Related]
38. Elevated prostate-specific antigen levels in black men and white men.
Sawyer R; Berman JJ; Borkowski A; Moore GW
Mod Pathol; 1996 Nov; 9(11):1029-32. PubMed ID: 8933511
[TBL] [Abstract][Full Text] [Related]
39. Age-specific reference ranges for serum prostate-specific antigen in black men.
Morgan TO; Jacobsen SJ; McCarthy WF; Jacobson DJ; McLeod DG; Moul JW
N Engl J Med; 1996 Aug; 335(5):304-10. PubMed ID: 8663870
[TBL] [Abstract][Full Text] [Related]
40. Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer.
Wulaningsih W; Astuti Y; Matsuguchi T; Anggrandariyanny P; Watkins J;
Prostate; 2017 Jan; 77(1):22-32. PubMed ID: 27566127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
